Back to the main directory
Company Analysis / Equity
- Fed Tightens Again, Removes 'Accommodative' Wording; Economic Signals Remain Strong For Now by Morningstar
- Colorado Proposition 112 Threatens Statewide Fracking Operations by Morningstar
- Pioneer Has Favorable Pricing Differentials Locked in as Permian Production Continues to Grow by Morningstar
- First round of nuclear project testimony appears to favor Scana-Dominion deal. by Morningstar
- Pentair's focus on operational improvements should boost earnings growth over the long run. by Morningstar
- Home Depot's competitive edge is intact as product offerings drive solid spring sales season. by Morningstar
- Morningstar | Daimler Reduces Guidance, Reports Preliminary EBIT for 3Q18; Maintaining EUR 85 FVE. See Updated Analyst Note from 21 Oct 2018 by Morningstar
- Morningstar | DLPH Updated Forecasts and Estimates from 19 Oct 2018 by Morningstar
- Jacobs Engineering Announces Sale of Energy, Chemicals & Resources Segment, Raising Our FVE by Morningstar
- Morningstar | Jacobs Engineering Announces Sale of Energy, Chemicals & Resources Segment, Raising Our FVE by Morningstar
- ä¸ä¿¡å»ºæŠ•(国际)ç ”ç©¶éƒ¨-æœé—»é¦™æ±Ÿï¼šä¸å›½å›½åŠ¡é™¢å®£å¸ƒè®¾ç«‹æ°‘è¥ä¼ä¸šå€ºåˆ¸èžèµ„支æŒå·¥å…·ï¼Œå¹¶ç”±ä¸å¤®æä¾›åˆå§‹èµ„金 by CSCI
- Cancellation of Domestic Data Roaming Fees Jolts China Unicom’s Growth in the 3Q by Morningstar
- Morningstar | Cancellation of Domestic Data Roaming Fees Jolts China Unicom’s Growth in the 3Q. See Updated Analyst Note from 22 Oct 2018 by Morningstar
- Morningstar | Cancellation of Domestic Data Roaming Fees Jolts China Unicom’s Growth in the 3Q. See Updated Analyst Note from 22 Oct 2018 by Morningstar
- Analyst Pin-board: DGW – 9M Results Update by Viet Dragon Securities
- Morningstar | Corporate Action: WorleyParsons in Value-Accretive Purchase of Jacobs ECR. FVE Upgraded to AUD 9.00. See Updated Analyst Note from 22 Oct 2018 by Morningstar
- Brambles’s 1Q Results Highlight Further Cost Inflation, but Revenue On Pace; Shares Fairly Valued by Morningstar
- MOSL: HINDUSTAN ZINC (Neutral)-In-line-announces huge dividend; capacity expansion on track by Motilal Oswal
- MOSL: ALEMBIC PHARMACEUTICALS (Neutral)-One-time US sales drive better-than-expected performance by Motilal Oswal
- MOSL: JUBILANT LIFE SCIENCES (Buy)-Profitability driven by Pharmaceutical biz by Motilal Oswal
- MOSL: BIOCON (Neutral)-Positive Committee opinion-However, launch subject to multiple factors by Motilal Oswal
- MOSL: Morning India (23/October/18): 1. GAIL; 2. Asian Paints; 3. Hindustan Zinc; 4. GSK Pharma; 5. Oberoi Realty; 6. Alembic Pharma; 7. Jubilant Life Sciences; 8. Persistent Systems; 9. S H Kelkar; 10. Metals by Motilal Oswal
- Healthscope More Likely to Be Acquired This Time Following BGH Consortium Return by Morningstar
- Morningstar | Healthscope More Likely to Be Acquired This Time Following BGH Consortium Return. See Updated Analyst Note from 22 Oct 2018 by Morningstar
- Morningstar | Menu Changes, Streamlined Operations, and Off-Premises Sales Make Darden a Casual Dining Standout. by Morningstar